Substance Treatment and HIV Testing and Referral System
STaRS
Substance Treatment Referral System
2 other identifiers
interventional
60
1 country
1
Brief Summary
The lack of substance screening and referral in healthcare settings is a significant problem with far-reaching consequences, including excess morbidity, premature mortality, and inflated healthcare costs. An easy to use, time-efficient referral system is needed to address this problem. The Substance Treatment Referral Systems (STaRS), a computer assisted screening and referral system, was developed to meet this need. STaRS Phase I demonstrated the feasibility of STaRS to meet this need. All aims and evaluation goals of the Phase I study were met or exceeded. The purpose of the Phase II research is to demonstrate the clinical utility and commercial viability of STaRS. Specific Aims of Phase II are:
- 1.Integrate STaRS with the Epic electronic health record used in the Cooper Health System in Camden, N.J.
- 2.Document STaRS' effectiveness in (a) increasing the number of referrals provided for substance abuse treatment and HIV screening, and (b) increasing the proportion of patients that initiate specialty treatment.
- 3.Evaluate clinician acceptance and impact upon revenue generation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Dec 2011
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2011
CompletedStudy Start
First participant enrolled
December 1, 2011
CompletedFirst Posted
Study publicly available on registry
December 8, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedJuly 18, 2018
July 1, 2018
1.2 years
December 1, 2011
July 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Referral Rates for Substance Abuse Treatment and HIV Testing
A total of 7000 electronic health records ( referred to as "charts") will be reviewed for referral rates. Those charts include 3500 pre-STaRS charts (treatment as usual arm) and 3500 STaRS charts (intervention arm)
Completed after 3500 pre-STaRS charts and 3500 STaRS intervention charts are reviewed, over a period of one year
Secondary Outcomes (3)
Treatment Initiation
70 pre-STarS patients and 70 STaRS patients are enrolled, over a period of six months
Billing Revenue
7000 charts reviewed, over a period of one year
Provider Satisfaction
Last month of the study, November 2012
Study Arms (2)
Treatment as Usual
NO INTERVENTIONChart review only.
STaRS
EXPERIMENTALPatients asked to participate in follow-up study to get information on whether they went to referral recommended by their provider through the STaRS system.
Interventions
The intervention entails testing an automated substance abuse treatment referral system (STaRS) to be implemented in primary care practices through electronic health record systems to improve 1) referral rates to specialty care providers, 2) patient treatment initiation with the specialty care providers, and 3) revenues to the practices.
Eligibility Criteria
You may qualify if:
- All English-speaking adult patients (\>= 18 years old) who received a referral for substance abuse treatment or HIV/AIDS screening from Cooper Family Medicine practices during the study period, and who can be reached at a home telephone or have a monthly cell phone plan.
You may not qualify if:
- Patients \< 18 years old and patients with poor English comprehension, or who do not have reliable telephone access (i.e., no phone access or buys minutes for a "disposable" cell phone)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Polaris Health Directionslead
- University of Massachusetts, Worcestercollaborator
Study Sites (1)
Cooper Family Medicine
Camden, New Jersey, 08102, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Grant Grissom, PhD
Polaris Health Directions
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2011
First Posted
December 8, 2011
Study Start
December 1, 2011
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
July 18, 2018
Record last verified: 2018-07